SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-18-000215
Filing Date
2018-03-01
Accepted
2018-03-01 16:07:11
Documents
5
Period of Report
2018-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_55929.htm 8-K 17312
2 EX-99.1 exhibit1.htm EX-99.1 46093
3 EX-99.2 exhibit2.htm EX-99.2 4280
4 GRAPHIC e44347-1859856174717e3634_1.jpg GRAPHIC 12086
5 GRAPHIC e44347-18601435476793c7eb_1.jpg GRAPHIC 12182
  Complete submission text file 0001299933-18-000215.txt   103128
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 18657291
SIC: 2834 Pharmaceutical Preparations